Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RN7SK pseudogene 213 (RN7SKP213) is a human genomic pseudogene homologous to the RN7SK small nuclear RNA gene, which is part of a ribonucleoprotein complex involved in regulation of transcription elongation by RNA polymerase II. RN7SKP213 does not encode a functional RNA or protein and has no known biological function or disease association; it is annotated in human genome databases simply as a pseudogene, representing a non-functional remnant of the ancestral RN7SK sequence. Unlike the functional RN7SK gene, which is involved in transcription regulation and may play roles in epidermal cellularity and immune deficiency diseases, RN7SKP213 does not produce active RNA and is not considered a molecular target for therapy or research. Pseudogenes similar to RN7SKP213 are common for small RNAs and do not contribute known function to physiology or disease.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RN7SK pseudogene 213 (RN7SKP213).